Dive Brief:

Omada Health beat Wall Street expectations on earnings and revenue in the digital chronic condition management company’s public earnings debut on Thursday.

The firm reported revenue of $61.4 million in the second quarter, increasing 49% year over year. Omada posted a net loss of $5.3 million in the period, compared with $10.7 million during the second quarter in 2024.

The main drivers of revenue and membership growth included more customers using multiple chronic condition programs as well as strong adoption of GLP-1 offerings and improved marketing effectiveness, CFO Steve Cook said on an earnings call Thursday.

Dive Insight:

Omada hit the public markets in early June. The company, founded in 2011, offers digital management programs for conditions like diabetes, obesi

See Full Page